|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.15 EUR | -0.78% |
|
+9.00% | -11.38% |
| 12/06 | Euronext includes Maurel et Prom, Mersen in SBF 120, excludes Elior Group, Nexity | RE |
| 04/06 | Neurones S.A.'s Equity Buyback announced on October 21, 2025, has expired. | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | 52 | +36.3% | 1 | |||||
| 244.16 | +9.17% | 23 | |||||||
| 301.98 | +2.96% | 48 | |||||||
| 178.89 | +7.82% | 25 | |||||||
| 2,481.05 | +4.88% | 42 | |||||||
| 33.91 | +30.08% | 16 | |||||||
| 1,199.02 | +6.1% | 42 | |||||||
| 4,589.23 | +25.42% | 13 | |||||||
| 5,949.17 | +25.51% | 12 | |||||||
| 1,265.7 | -6.03% | 40 | |||||||
| 29.91 | +22.82% | 14 | |||||||
| 318 | +9.65% | 5 | |||||||
| 63.1 | +14.01% | 25 | |||||||
| 67.26 | +26.09% | 21 | |||||||
| 129.02 | -9.1% | 42 | |||||||
| 436.1 | +8.33% | 10 | |||||||
| 8,60,454.55 | +54.48% | 11 | |||||||
| 139.63 | +36.22% | 17 | |||||||
| 158.21 | +37.36% | 23 | |||||||
| Average | 46,215.31 | +18.00% | 23 | ||||||
| Weighted average by Cap. | 20,244.92 | +12.53% | 27 |
- Stock Market
- Stocks
- NRO Stock
- Sector NEURONES
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















